Latest Xaira Therapeutics News & Updates

See the latest news and media coverage for Xaira. We track all announcements, press releases, and industry mentions in real time, all in one place.

Xaira Therapeutics (Xaira)

AI-driven drug discovery company

xaira.com

Headquarters: South San Francisco, United States
Founded year: 2023
Company type: Private company
Number of employees: 50–225
Industry: Pharmaceuticals

Last updated Today

Latest news about Xaira Therapeutics (Xaira)

In short: Xaira Therapeutics launched with over $1 billion to transform drug discovery through AI-driven models and strategic leadership hiring.

Company announcements

July 6 Xaira

Xaira appoints McCaffery and promotes Chu and Wang

McCaffery will lead translational science and early clinical development, Chu becomes Chief Discovery Officer, Wang becomes Chief AI Scientist.

March 26 Xaira

Xaira welcomes Rachel Lane as SVP Business Development and Operations

Rachel brings deep biotech and investing experience from Belharra Therapeutics, where she led partnerships with Genentech and Sanofi. She will lead business development and scale AI drug discovery partnerships.

March 25 Xaira

Xaira launches AI in Residence program

It targets recent MS/PhD graduates for 6-12 month projects advancing models like X-Cell. Applications are now open.

March 17 Xaira

Xaira launches X-Cell virtual cell model

X-Cell is trained on the largest genome-wide perturbation dataset and predicts unseen experiment outcomes. It aims to transform drug discovery.

Media coverage

June 22 BioSpace

Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in

About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the...

March 26 The Standard Journal

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

Xaira Therapeutics today announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and Operations, reporting to President and COO Jeff Jonker...

March 23 The Business Journals

Xaira Therapeutics raised nearly $1 billion. Here's its next act

Funders committed nearly $1 billion toward this AI company. Here's its next act.

March 20 Fierce Biotech

Behind the curtain: What Xaira is building after its $1B fundraise

Since Xaira's eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. | What has Xaira been doing since its $1...

Never miss news about Xaira

Track Xaira and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Xaira competitors & trending companies

Browse news for competitors to Xaira and other trending companies.